Expert Opinion on Drug Discovery

Expert Opinion on Drug Discovery (ISSN 1746-0441) is a prestigious monthly international journal published by Informa Healthcare in the United Kingdom, dedicated to advancing the field of drug discovery through high-impact scholarly discourse. As an SCI-indexed publication that consistently ranks in the upper quartiles of the medical and pharmaceutical sciences according to the Chinese Academy of Sciences (CAS) journal ranking system, the journal holds a strong reputation within the academic community. Its scope encompasses critical areas such as drug design, target identification, preclinical development, and translational medicine, with a particular emphasis on expert reviews and commentary articles that synthesize current trends and offer forward-looking insights. While the journal is not fully open access, it offers selective open access options, and authors are encouraged to submit work that provides innovative perspectives on drug discovery, noting that the publication prioritizes authoritative opinion and synthesis over purely empirical data-driven studies. Consequently, it serves as a vital platform for researchers and industry professionals seeking to disseminate high-level strategic insights and interpretive analyses in the pharmaceutical sciences.